BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10778198)

  • 1. [Human chorionic gonadotropin beta-core fragment (hCG beta-cf)].
    Okamoto T
    Nihon Rinsho; 1999 Dec; 57 Suppl():586-8. PubMed ID: 10778198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():803-6. PubMed ID: 20963909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():765-7. PubMed ID: 16149635
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
    Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.
    Schutter EM; Mulder C; van Kamp GJ; Kenemans P
    Anticancer Res; 1997; 17(2B):1255-72. PubMed ID: 9137483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K; Shahabi S; Cole L
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
    Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M; Navaglia F; Basso D; De Paoli M; Nicoletto MO; Maraglino E; Torre GC
    Anticancer Res; 1996; 16(6B):3833-8. PubMed ID: 9042266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [false-positive results of human chorionic gonadotropin β measurement after high orchiectomy for stage i seminoma: report of a case].
    Tomita K; Nishikawa N; Takimoto K; Kim CJ
    Hinyokika Kiyo; 2010 Nov; 56(11):663-5. PubMed ID: 21187715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UGP in urogenital disorders: Egyptian experience.
    el-Ahmady O; Halim AB; Gad M; Walker R
    Anticancer Res; 1996; 16(4B):2301-8. PubMed ID: 8694560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors].
    Lechner O; Dirnhofer S; Gerth R; Merz WE; Wick G; Berger P
    Wien Klin Wochenschr; 1995; 107(1):15-9. PubMed ID: 7871785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New endocrine tumor markers of gynecologic malignancies. A review.
    Kauppila A; Santala M
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):833-7. PubMed ID: 10577610
    [No Abstract]   [Full Text] [Related]  

  • 17. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
    Ordóñez NG; Ayala AG; Raymond AK; Plager C; Benjamin RS; Samaan NA
    Arch Pathol Lab Med; 1989 Apr; 113(4):416-9. PubMed ID: 2468324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R; Crebbin V; Stern J; Scudder S; Schwartz P
    Anticancer Res; 1994; 14(5A):1703-9. PubMed ID: 7847804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.